Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,786,812
+$255,147 QoQ
Shares Held
10,973
+5.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#2,052
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Knuff & Co LLC holds $24,047,308 across 10 Drug Manufacturers - General names. JNJ ranks #2 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
242,776 | $11,638,681 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
10,973 | $2,786,812 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
17,641 | $2,228,763 | |
| 4 | ABBV |
AbbVie Inc.
|
8,555 | $2,152,780 | |
| 5 | MRK |
Merck & Co., Inc.
|
13,038 | $1,675,383 | |
| 6 | PFE |
Pfizer Inc
|
63,859 | $1,537,724 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
16,438 | $947,157 | |
| 8 | AMGN |
Amgen Inc
|
1,800 | $651,816 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,786,812 | 10,973 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,531,665 | 10,357 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,706,716 | 8,247 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,438,302 | 7,757 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,215,431 | 7,957 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,319,588 | 7,957 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,358,560 | 9,394 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,534,059 | 9,466 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,374,196 | 9,402 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,487,302 | 9,402 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,173,982 | 7,490 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,471,681 | 9,449 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,927,717 | 17,688 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,797,595 | 18,049 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $3,522,224 | 19,939 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $3,255,274 | 19,927 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,895,274 | 10,677 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,892,284 | 10,677 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,053,011 | 12,001 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,292,161 | 8,001 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,318,084 | 8,001 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,314,964 | 8,001 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,267,066 | 8,051 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $1,207,714 | 8,112 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $1,056,271 | 7,511 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $841,461 | 6,417 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||